Lisanti Capital Growth, LLC Tg Therapeutics, Inc. Transaction History

Lisanti Capital Growth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$15.48 - $35.0 $2.99 Million - $6.77 Million	193,460 New	193,460 $4.81 Million
Q3 2021 Nov 03, 2021	SELL	$21.78 - $40.45 $2.44 Million - $4.53 Million	-111,955 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $3.64 Million - $5.48 Million	111,955 New	111,955 $4.34 Million
Q3 2020 Nov 05, 2020	SELL	$18.49 - $27.24 $3.47 Million - $5.12 Million	-187,795 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$8.9 - $21.84 $851,240 - $2.09 Million	95,645 Added 103.79%	187,795 $3.66 Million
Q1 2020 May 11, 2020	BUY	$7.14 - $15.99 $657,951 - $1.47 Million	92,150 New	92,150 $907,000

338

87.6M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.22B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.